SlideShare a Scribd company logo
University of Delaware
Department of Chemistry
12/7/2015
Excited States and Conformational
Rearrangement: What do they tell us about
Chaperone Action?
Stress Chaperones
Human HSPB5
 sHSPs are found in all kingdoms and serve as ATP-
Independent chaperones.
 Human HSPB5 originally found in the
eye-lens is associated with cataracts
and myopathies.
 Also overexpressed in breast cancers; implicated in
the development of chemo-resistance
 HSPB5 overexpressed in neuro-degenerative
diseases such as Alzheimer’s
HSPB5: A Challenge for Structure Determination
Aquilina et al., (2003). PNAS
 Methods of Structure Determination: Crystallography and
NMR
 HSPB5: Polydisperse oligomer
 Tandem Mass Spectrometry : Oligomers ranging in size from
24-33 subunits coexist in equilibrium.
 ~ 580 kDa; Each subunit = 20 kDa
 Lower levels of
oligomers ranging in
size from 10-mers to
40-mers are also
found.
Method of Structure Determination
 MAS solid-state NMR
 Solution-state NMR
 Electron Microscopy (EM)
 Small Angle X-ray Scattering (SAXS)
 Rigid body Energy minimization
 Correlations between NMR active nuclei , 1H, 13C, and 15N:
distance restraints between residues in a protein
 Solid-state NMR: 13C or 15N detected.
 Solution-state NMR : 1H detected.
 Multimers: Distinguish between intra- and inter subunits
restraints.
15N 13C+ NHHCINTER
INTRA 15N 13COR
Mix 20% labeled with
80% unlabeled
Jehle and Oschkinat
Regions of NHHC Spectra : Inter-Subunit Correlations.
PSEUDO-ATOMIC MODEL OF HSPB5
Jehle et al. (2011). PNAS
Peschek et al. (2009). PNAS
24 subunits were
placed in EM-density
map and energy
minimized.
Hierarchical Assembly of the Oligomer
N
C
Substrate Binding Regions are Buried.
Misfolded
Protein
A peptide
(Alzheimer’s)
• N-terminal regional
binds misfolded
proteins.
• A peptide binds a
groove in ACD.
Mainz et al.,
(2015). NSMB
Is a conformational rearrangement
of HSPB5 oligomer necessary to
expose substrate-binding regions to
substrates?
Cellular stress and pH
 Acute cellular stresses associated with acidosis.
 pH in mouse brain following ischemic stroke drops to
pH 6.5 from pH 7.0. Shown by CEST NMR (McVicar et
al., 2014)
 Decrease in cellular pH can lead to
destabilization/decrease in solubility of some
proteins.
 Investigate HSPB5 at pH 6.5
13C-13C PDSD spectra.
I133 & T134 in ACD
Groove
ssNMR Spectra Show Evidence of a Different
Conformation at pH 6.5.
In lieu of spending another 5
years, using vast amounts of
NMR time and saving money
for us and NIH….
Structural Biologists’ favorite
tool:
DIVIDE and CONQUER!
A Conserved Domain Suitable for NMR Studies
ACD
 20 kDa homodimer in solution
 ACD is conserved in all sHSPs
 NOEs & RDCs & chemical shifts: RosettaOligomer
 Homodimer: 6-stranded -sheet in each protomer
 Dimer interface: 10-residue -strand
SOLUTION STRUCTURE OF HSPB5-ACD
Solution structure of the ACD is similar to the structure of the ACD
dimer in the oligomer.
pH 7.5, 22 °C
Protein Dynamics from Solution State NMR.
Lineshapes in NMR Spectra
CPMG Experiments
CPMG Experiments Show that ACD has a minor conformation at
pH 7.5.
Map of residues showing
exchange at pH 7.5, 22 °C
• A contiguous region at the dimer
interface shows exchange implying a
concerted motion in that region.
• Dimer-Monomer equilibrium?
Concentration Dependence of Exchange Rate
(ACD)2 2(ACD)
kex = kdm + kmd[ACD]
kdm
kmd
• kex varies with concentration: Exchange is due to dimer-monomer
equilibrium.
• Analysis of CPMG data: pB ~5%
• KD from ITC shows that [monomer] is ~4%
Residue [ACD] (mM) kex (s-1)
119 0.7 ~1119
119 0.2 ~612
122 0.7 ~1163
122 0.2 ~100
The minor conformation at pH 7.5 and 22 °C is a monomer.
ACD and pH
1H-15N TROSY of ACD at pH 7.5 and pH 6.5
Peak doubling observed at pH 6.5 indicates the presence of two
conformations.
The Second Conformation at pH 6.5 is the Monomer
KD from ITC
pH KD (mM)
7.5 ~0.002
6.5 ~0.030
Surface Mapping of Residues (Red) Showing Peak Doubling
Dimer interface
• Increase in KD with drop in pH:
Increase in monomer population.
• AUC (Analytical
UltraCentrifugation)and SEC (Size
Exclusion Chromatography) further
confirm presence of both dimer and
monomer populations at pH 6.5
The Invisible, Excited State at pH 7.5 Becomes
More Populated at pH 6.5
Map of residues showing
exchange at pH 7.5
Residues showing peak
doubling at pH 6.5
B calc  B exptl
B(ppm)
• Dimer-monomer transition occurs in the pH range 7.5-6.5
• Imidazole rings of Histidines titrate in this range.
Residues Responsible for Dimer-Monomer Transition.
• Positively charged histidine can be mimicked by
positively charged lysine.
Histidines in ACD
180°
 A total of 10 histidines in ACD; 5 per protomer
 Mutated to Lysine
H104K-ACD is a Monomer
Regions 1H-15N HSQC Spectra
ACD at pH 6.5
H104K-ACD
15N(ppm)
AUC confirms
H104K-ACD is a
monomer.
How is the activity of oligomeric HSPB5
affected by the mutation H104K?
H104K-HSPB5 is a Better Chaperone
Model substrate: Lactalbumin (Lac)
Lac destabilized Lac aggregates
(scatter light)
DTT
Activity of HSPB5 monitored by its ability to delay scattering
H104K delays
scattering.
What makes H104K-HSPB5 a better
chaperone?
Investigate size and morphology by
SEC-MALS and negative-stain EM.
H104K forms assemblies similar to WT at pH6.5
SEC-MALS Negative Stain EM
WT
(pH 7.5)
WT
(pH 6.5)
465 kDa 720 kDaMW
# subunits ~24 ~36
<“diameter”>
H104K
(pH 7.5)
810 kDa
~41
15 (13-17) 16 (14->18) 17 (15->19)
Average Oligomer Size
Tse
SEC-MALS of HSPB5 and H104K-HSPB5 + Lac
SEC-MALS
Hydrodynamic Radius Hydrodynamic Radius
Tse
EM
Peak 1 and Peak II from SEC-MALS
Tse
H104K-HSPB5 forms smaller, longer-lived complexes
with destabilized Lac.
Fluorescence of ANS + H104K-HSPB5 > HSPB5
0.00E+00
1.00E+05
2.00E+05
3.00E+05
4.00E+05
5.00E+05
6.00E+05
7.00E+05
8.00E+05
9.00E+05
1.00E+06 400
411
422
433
444
455
466
477
488
499
510
521
532
543
554
565
576
587
598
609
620
631
642
653
H104K
HSPB5
Increased fluorescence :
greater hydrophobicity
Conclusions
• Structure of HSPB5 solved by hybrid methodology.
• The minor conformation in ACD is stabilized by the
mutation, H104K.
• H104K-HSPB5 is a better holdase, forms smaller longer
-lived complexes with denatured model substrate.
• The sampling of active conformational states and
rearrangement under stress: hallmark of sHSPs?
Acknowledgements
University of WA, Seattle
Rachel E.Klevit
Andrew Borst
Joseph Stout
David Fox
Amanda Clouser
Katja Dove
Scott Delbecq
Lisa Tuttle
EM and SEC-MALS,U of
Michigan
Dan Southworth
Eric Tse
Solid State NMR, FMP Berlin
Harmtut Oschkinat
Stefan Jehle
Benjamin Bardiaux
RosettaOligomer
David Baker
Nik Sgourakis
Lei Shi
NIH/NEI
• Dimer-monomer transition occurs in the pH range 7.5-6.5
• Imidazole rings of Histidines titrate in this range.
• Monitor the chemical shift changes of ring carbon-bound
protons and nitrogens as a function of pH. Determine pKr
values.
Residues Responsible for Dimer-Monomer Transition?
Protonation of a Single Histidine Favors the
Monomeric Form of ACD.
180°
6.6
?
<6<5
7.7
• pKr values shown in red
• His 83Gln: No effect
• His104Gln :Both dimer and monomer forms are observed at
pH 7.5 and 6.5
• His104Lys: Monomer at pH 7.5 and 6.5
Tautomeric States of Histidines in WT-ACD15Nppm
H104
H119
H111
H ppm
At Physiological Temperatures….
Solution State NMR performed at 22 °C to observe maximum
number of resonances.
Temperature (°C) [ACD](mM) kex (s-1)
37 0.7 1512 ±225
37 0.2 460±100
22 0.7 926±269
(ACD)2 2(ACD)
kex = kdm + kmd[ACD]
kdm
kmd
G = -RTlnKeq
pA = 0.096, pB = 0.04
G = 8.2 kJ mol-1
Conformational change is not
spontaneous. Stresses such as
acidosis or elevation in temperature
drive conformational change.
 HSPB5: ~580 kDa oligomer, 10-32 subunits.
 Each subunit: Conserved -crystallin domain
(ACD) + variable N- and C-termini.
 There are 10 human sHSPs.
 Polydisperse oligomers.
 B-Crystallin (HSPB5) seems to have evolved to
resist crystallization!
INTRODUCTION and OUTLINE
 MAS solid-state NMR and EM: model of HSPB5
oligomer
 Solution state studies on the ACD domain:
functional questions

More Related Content

What's hot

Acta Crystalo D
Acta Crystalo DActa Crystalo D
Acta Crystalo D
Rikeshwer Prasad Dewangan
 
Tumor proteins
Tumor proteinsTumor proteins
Tumor proteins
Brad Pamnani
 
Cryptic pocket
Cryptic pocketCryptic pocket
Cryptic pocket
RAHUL VIVEK
 
PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52
Dinesh Barawkar
 
Synthesis and Characterization of the Epimers of 2-Chloroadenosine
Synthesis and Characterization of the Epimers of 2-ChloroadenosineSynthesis and Characterization of the Epimers of 2-Chloroadenosine
Synthesis and Characterization of the Epimers of 2-Chloroadenosine
realjimcarey
 
poster for Jay%27s lab (2)
poster for Jay%27s lab (2)poster for Jay%27s lab (2)
poster for Jay%27s lab (2)
Shiva Dastjerdi
 
Salts and proteins
Salts and proteinsSalts and proteins
Salts and proteins
mganguly123
 
Automated DNA sequencing ; Protein sequencing
Automated DNA sequencing ; Protein sequencingAutomated DNA sequencing ; Protein sequencing
Automated DNA sequencing ; Protein sequencing
Rima Joseph
 
D sc peptide1
D sc peptide1D sc peptide1
D sc peptide1
mganguly123
 
9700 s03 qp_1
9700 s03 qp_19700 s03 qp_1
9700 s03 qp_1
Pohamba Mushelenga
 
DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017
Biology Exams 4 U
 
STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...
STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...
STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...
International Journal of Technical Research & Application
 
Nucleic Acids Reserach (1996) 24, 1229-1237
Nucleic Acids Reserach (1996) 24, 1229-1237Nucleic Acids Reserach (1996) 24, 1229-1237
Nucleic Acids Reserach (1996) 24, 1229-1237
Dinesh Barawkar
 
Jacs 3 pot_synthesis_article
Jacs 3 pot_synthesis_articleJacs 3 pot_synthesis_article
Jacs 3 pot_synthesis_article
AVIVE, INC.
 
9700 s03 ms_1+2+3+4+5+6
9700 s03 ms_1+2+3+4+5+69700 s03 ms_1+2+3+4+5+6
9700 s03 ms_1+2+3+4+5+6
Hoda Abdelfattah
 
PhD Federica III anno
PhD Federica III annoPhD Federica III anno
PhD Federica III anno
lab13unisa
 
PNAS paper 2007
PNAS paper 2007PNAS paper 2007
PNAS paper 2007
Jalal Hawari
 
Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...
Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...
Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...
Chromatography & Mass Spectrometry Solutions
 
ProteinSci2007
ProteinSci2007ProteinSci2007
ProteinSci2007
Je-Hyun Baek
 
9700 s11 qp_11
9700 s11 qp_119700 s11 qp_11
9700 s11 qp_11
smartexamresources
 

What's hot (20)

Acta Crystalo D
Acta Crystalo DActa Crystalo D
Acta Crystalo D
 
Tumor proteins
Tumor proteinsTumor proteins
Tumor proteins
 
Cryptic pocket
Cryptic pocketCryptic pocket
Cryptic pocket
 
PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52PNAS-1998-Barawkar-11047-52
PNAS-1998-Barawkar-11047-52
 
Synthesis and Characterization of the Epimers of 2-Chloroadenosine
Synthesis and Characterization of the Epimers of 2-ChloroadenosineSynthesis and Characterization of the Epimers of 2-Chloroadenosine
Synthesis and Characterization of the Epimers of 2-Chloroadenosine
 
poster for Jay%27s lab (2)
poster for Jay%27s lab (2)poster for Jay%27s lab (2)
poster for Jay%27s lab (2)
 
Salts and proteins
Salts and proteinsSalts and proteins
Salts and proteins
 
Automated DNA sequencing ; Protein sequencing
Automated DNA sequencing ; Protein sequencingAutomated DNA sequencing ; Protein sequencing
Automated DNA sequencing ; Protein sequencing
 
D sc peptide1
D sc peptide1D sc peptide1
D sc peptide1
 
9700 s03 qp_1
9700 s03 qp_19700 s03 qp_1
9700 s03 qp_1
 
DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017DBT BET JRF Exam Question Paper 2016 and 2017
DBT BET JRF Exam Question Paper 2016 and 2017
 
STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...
STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...
STUDY OF MOLAR REFRACTION AND POLARISABILITY CONSTANT OF AQUEOUS SOLUTIONS OF...
 
Nucleic Acids Reserach (1996) 24, 1229-1237
Nucleic Acids Reserach (1996) 24, 1229-1237Nucleic Acids Reserach (1996) 24, 1229-1237
Nucleic Acids Reserach (1996) 24, 1229-1237
 
Jacs 3 pot_synthesis_article
Jacs 3 pot_synthesis_articleJacs 3 pot_synthesis_article
Jacs 3 pot_synthesis_article
 
9700 s03 ms_1+2+3+4+5+6
9700 s03 ms_1+2+3+4+5+69700 s03 ms_1+2+3+4+5+6
9700 s03 ms_1+2+3+4+5+6
 
PhD Federica III anno
PhD Federica III annoPhD Federica III anno
PhD Federica III anno
 
PNAS paper 2007
PNAS paper 2007PNAS paper 2007
PNAS paper 2007
 
Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...
Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...
Chromatography: Protein Characterization by Hydrogen/Deuterium Exchange Mass ...
 
ProteinSci2007
ProteinSci2007ProteinSci2007
ProteinSci2007
 
9700 s11 qp_11
9700 s11 qp_119700 s11 qp_11
9700 s11 qp_11
 

Similar to ppt_12072015

Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)
Peter Kenny
 
Cubic Phase Nanoparticles
Cubic Phase NanoparticlesCubic Phase Nanoparticles
Cubic Phase Nanoparticles
asarode
 
Nanotechnology and its Application in Cancer Treatment
Nanotechnology and its Application in Cancer TreatmentNanotechnology and its Application in Cancer Treatment
Nanotechnology and its Application in Cancer Treatment
Hasnat Tariq
 
Fragment based drug design complementary tool for drug design
Fragment based drug design  complementary tool for drug designFragment based drug design  complementary tool for drug design
Fragment based drug design complementary tool for drug design
NIPER hyderabad
 
Research poster 2
Research poster 2Research poster 2
Research poster 2
Kyra Thrush
 
Lecture 18
Lecture 18Lecture 18
Lecture 18
Zaib Chaudhry
 
1692.pdf
1692.pdf1692.pdf
HUGH THESIS
HUGH THESISHUGH THESIS
HUGH THESIS
Hugh Morgan
 
ABRCMS Poster2012
ABRCMS Poster2012ABRCMS Poster2012
ABRCMS Poster2012
Mayra Pedraza
 
Dna rna-13
Dna rna-13Dna rna-13
Dna rna-13
kuldip sodhi
 
Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)
Peter Kenny
 
Lecture 6
Lecture 6Lecture 6
phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...
phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...
phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...
bnvj
 
Dna methylation field guide 20130806
Dna methylation field guide 20130806Dna methylation field guide 20130806
Dna methylation field guide 20130806
abizarl
 
liquid crystal phase
liquid crystal phaseliquid crystal phase
liquid crystal phase
Raees Ahmad
 
CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...
CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...
CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...
Chad Schwartz
 
housman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percenthousman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percent
Jonathan Oyler
 
STRING - Modeling of biological systems through cross-species data integration
STRING - Modeling of biological systems through cross-species data integrationSTRING - Modeling of biological systems through cross-species data integration
STRING - Modeling of biological systems through cross-species data integration
Lars Juhl Jensen
 
Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)
Peter Kenny
 
Synthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acid
Synthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acidSynthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acid
Synthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acid
SSR Institute of International Journal of Life Sciences
 

Similar to ppt_12072015 (20)

Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)Design of fragment screening libraries (IQPC 2008)
Design of fragment screening libraries (IQPC 2008)
 
Cubic Phase Nanoparticles
Cubic Phase NanoparticlesCubic Phase Nanoparticles
Cubic Phase Nanoparticles
 
Nanotechnology and its Application in Cancer Treatment
Nanotechnology and its Application in Cancer TreatmentNanotechnology and its Application in Cancer Treatment
Nanotechnology and its Application in Cancer Treatment
 
Fragment based drug design complementary tool for drug design
Fragment based drug design  complementary tool for drug designFragment based drug design  complementary tool for drug design
Fragment based drug design complementary tool for drug design
 
Research poster 2
Research poster 2Research poster 2
Research poster 2
 
Lecture 18
Lecture 18Lecture 18
Lecture 18
 
1692.pdf
1692.pdf1692.pdf
1692.pdf
 
HUGH THESIS
HUGH THESISHUGH THESIS
HUGH THESIS
 
ABRCMS Poster2012
ABRCMS Poster2012ABRCMS Poster2012
ABRCMS Poster2012
 
Dna rna-13
Dna rna-13Dna rna-13
Dna rna-13
 
Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)Fragment screening library workshop (IQPC 2008)
Fragment screening library workshop (IQPC 2008)
 
Lecture 6
Lecture 6Lecture 6
Lecture 6
 
phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...
phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...
phw1wyuuswgwao8gzhfj-signature-091447bade647bc70325d98b994f7c3a3901d946a34a45...
 
Dna methylation field guide 20130806
Dna methylation field guide 20130806Dna methylation field guide 20130806
Dna methylation field guide 20130806
 
liquid crystal phase
liquid crystal phaseliquid crystal phase
liquid crystal phase
 
CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...
CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...
CENT-1206APP11.15-A_Characterizing RNA Nanoparticles by Analytical Ultracentr...
 
housman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percenthousman_mini_4_5 foot PPT poster template 50 percent
housman_mini_4_5 foot PPT poster template 50 percent
 
STRING - Modeling of biological systems through cross-species data integration
STRING - Modeling of biological systems through cross-species data integrationSTRING - Modeling of biological systems through cross-species data integration
STRING - Modeling of biological systems through cross-species data integration
 
Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)Design of fragment screening libraries (Feb 2010 version)
Design of fragment screening libraries (Feb 2010 version)
 
Synthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acid
Synthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acidSynthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acid
Synthesis of 2,3 o,o-dibenzyl-6-o-tosyl-l-ascorbic acid
 

ppt_12072015

  • 1. University of Delaware Department of Chemistry 12/7/2015 Excited States and Conformational Rearrangement: What do they tell us about Chaperone Action?
  • 3. Human HSPB5  sHSPs are found in all kingdoms and serve as ATP- Independent chaperones.  Human HSPB5 originally found in the eye-lens is associated with cataracts and myopathies.  Also overexpressed in breast cancers; implicated in the development of chemo-resistance  HSPB5 overexpressed in neuro-degenerative diseases such as Alzheimer’s
  • 4. HSPB5: A Challenge for Structure Determination Aquilina et al., (2003). PNAS  Methods of Structure Determination: Crystallography and NMR  HSPB5: Polydisperse oligomer  Tandem Mass Spectrometry : Oligomers ranging in size from 24-33 subunits coexist in equilibrium.  ~ 580 kDa; Each subunit = 20 kDa  Lower levels of oligomers ranging in size from 10-mers to 40-mers are also found.
  • 5. Method of Structure Determination  MAS solid-state NMR  Solution-state NMR  Electron Microscopy (EM)  Small Angle X-ray Scattering (SAXS)  Rigid body Energy minimization
  • 6.  Correlations between NMR active nuclei , 1H, 13C, and 15N: distance restraints between residues in a protein  Solid-state NMR: 13C or 15N detected.  Solution-state NMR : 1H detected.  Multimers: Distinguish between intra- and inter subunits restraints. 15N 13C+ NHHCINTER INTRA 15N 13COR Mix 20% labeled with 80% unlabeled
  • 8. Regions of NHHC Spectra : Inter-Subunit Correlations.
  • 9. PSEUDO-ATOMIC MODEL OF HSPB5 Jehle et al. (2011). PNAS Peschek et al. (2009). PNAS 24 subunits were placed in EM-density map and energy minimized.
  • 10. Hierarchical Assembly of the Oligomer N C
  • 11. Substrate Binding Regions are Buried. Misfolded Protein A peptide (Alzheimer’s) • N-terminal regional binds misfolded proteins. • A peptide binds a groove in ACD. Mainz et al., (2015). NSMB
  • 12. Is a conformational rearrangement of HSPB5 oligomer necessary to expose substrate-binding regions to substrates?
  • 13. Cellular stress and pH  Acute cellular stresses associated with acidosis.  pH in mouse brain following ischemic stroke drops to pH 6.5 from pH 7.0. Shown by CEST NMR (McVicar et al., 2014)  Decrease in cellular pH can lead to destabilization/decrease in solubility of some proteins.  Investigate HSPB5 at pH 6.5
  • 14. 13C-13C PDSD spectra. I133 & T134 in ACD Groove ssNMR Spectra Show Evidence of a Different Conformation at pH 6.5.
  • 15. In lieu of spending another 5 years, using vast amounts of NMR time and saving money for us and NIH…. Structural Biologists’ favorite tool: DIVIDE and CONQUER!
  • 16. A Conserved Domain Suitable for NMR Studies ACD  20 kDa homodimer in solution  ACD is conserved in all sHSPs
  • 17.  NOEs & RDCs & chemical shifts: RosettaOligomer  Homodimer: 6-stranded -sheet in each protomer  Dimer interface: 10-residue -strand SOLUTION STRUCTURE OF HSPB5-ACD Solution structure of the ACD is similar to the structure of the ACD dimer in the oligomer. pH 7.5, 22 °C
  • 18. Protein Dynamics from Solution State NMR.
  • 19. Lineshapes in NMR Spectra CPMG Experiments
  • 20.
  • 21. CPMG Experiments Show that ACD has a minor conformation at pH 7.5. Map of residues showing exchange at pH 7.5, 22 °C • A contiguous region at the dimer interface shows exchange implying a concerted motion in that region. • Dimer-Monomer equilibrium?
  • 22. Concentration Dependence of Exchange Rate (ACD)2 2(ACD) kex = kdm + kmd[ACD] kdm kmd • kex varies with concentration: Exchange is due to dimer-monomer equilibrium. • Analysis of CPMG data: pB ~5% • KD from ITC shows that [monomer] is ~4% Residue [ACD] (mM) kex (s-1) 119 0.7 ~1119 119 0.2 ~612 122 0.7 ~1163 122 0.2 ~100 The minor conformation at pH 7.5 and 22 °C is a monomer.
  • 23. ACD and pH 1H-15N TROSY of ACD at pH 7.5 and pH 6.5 Peak doubling observed at pH 6.5 indicates the presence of two conformations.
  • 24. The Second Conformation at pH 6.5 is the Monomer KD from ITC pH KD (mM) 7.5 ~0.002 6.5 ~0.030 Surface Mapping of Residues (Red) Showing Peak Doubling Dimer interface • Increase in KD with drop in pH: Increase in monomer population. • AUC (Analytical UltraCentrifugation)and SEC (Size Exclusion Chromatography) further confirm presence of both dimer and monomer populations at pH 6.5
  • 25. The Invisible, Excited State at pH 7.5 Becomes More Populated at pH 6.5 Map of residues showing exchange at pH 7.5 Residues showing peak doubling at pH 6.5 B calc  B exptl B(ppm)
  • 26. • Dimer-monomer transition occurs in the pH range 7.5-6.5 • Imidazole rings of Histidines titrate in this range. Residues Responsible for Dimer-Monomer Transition. • Positively charged histidine can be mimicked by positively charged lysine.
  • 27. Histidines in ACD 180°  A total of 10 histidines in ACD; 5 per protomer  Mutated to Lysine
  • 28. H104K-ACD is a Monomer Regions 1H-15N HSQC Spectra ACD at pH 6.5 H104K-ACD 15N(ppm) AUC confirms H104K-ACD is a monomer.
  • 29. How is the activity of oligomeric HSPB5 affected by the mutation H104K?
  • 30. H104K-HSPB5 is a Better Chaperone Model substrate: Lactalbumin (Lac) Lac destabilized Lac aggregates (scatter light) DTT Activity of HSPB5 monitored by its ability to delay scattering H104K delays scattering.
  • 31. What makes H104K-HSPB5 a better chaperone? Investigate size and morphology by SEC-MALS and negative-stain EM.
  • 32. H104K forms assemblies similar to WT at pH6.5 SEC-MALS Negative Stain EM WT (pH 7.5) WT (pH 6.5) 465 kDa 720 kDaMW # subunits ~24 ~36 <“diameter”> H104K (pH 7.5) 810 kDa ~41 15 (13-17) 16 (14->18) 17 (15->19) Average Oligomer Size Tse
  • 33. SEC-MALS of HSPB5 and H104K-HSPB5 + Lac SEC-MALS Hydrodynamic Radius Hydrodynamic Radius Tse
  • 34. EM Peak 1 and Peak II from SEC-MALS Tse H104K-HSPB5 forms smaller, longer-lived complexes with destabilized Lac.
  • 35. Fluorescence of ANS + H104K-HSPB5 > HSPB5 0.00E+00 1.00E+05 2.00E+05 3.00E+05 4.00E+05 5.00E+05 6.00E+05 7.00E+05 8.00E+05 9.00E+05 1.00E+06 400 411 422 433 444 455 466 477 488 499 510 521 532 543 554 565 576 587 598 609 620 631 642 653 H104K HSPB5 Increased fluorescence : greater hydrophobicity
  • 36. Conclusions • Structure of HSPB5 solved by hybrid methodology. • The minor conformation in ACD is stabilized by the mutation, H104K. • H104K-HSPB5 is a better holdase, forms smaller longer -lived complexes with denatured model substrate. • The sampling of active conformational states and rearrangement under stress: hallmark of sHSPs?
  • 37. Acknowledgements University of WA, Seattle Rachel E.Klevit Andrew Borst Joseph Stout David Fox Amanda Clouser Katja Dove Scott Delbecq Lisa Tuttle EM and SEC-MALS,U of Michigan Dan Southworth Eric Tse Solid State NMR, FMP Berlin Harmtut Oschkinat Stefan Jehle Benjamin Bardiaux RosettaOligomer David Baker Nik Sgourakis Lei Shi NIH/NEI
  • 38. • Dimer-monomer transition occurs in the pH range 7.5-6.5 • Imidazole rings of Histidines titrate in this range. • Monitor the chemical shift changes of ring carbon-bound protons and nitrogens as a function of pH. Determine pKr values. Residues Responsible for Dimer-Monomer Transition?
  • 39. Protonation of a Single Histidine Favors the Monomeric Form of ACD. 180° 6.6 ? <6<5 7.7 • pKr values shown in red • His 83Gln: No effect • His104Gln :Both dimer and monomer forms are observed at pH 7.5 and 6.5 • His104Lys: Monomer at pH 7.5 and 6.5
  • 40. Tautomeric States of Histidines in WT-ACD15Nppm H104 H119 H111 H ppm
  • 41. At Physiological Temperatures…. Solution State NMR performed at 22 °C to observe maximum number of resonances. Temperature (°C) [ACD](mM) kex (s-1) 37 0.7 1512 ±225 37 0.2 460±100 22 0.7 926±269 (ACD)2 2(ACD) kex = kdm + kmd[ACD] kdm kmd
  • 42. G = -RTlnKeq pA = 0.096, pB = 0.04 G = 8.2 kJ mol-1 Conformational change is not spontaneous. Stresses such as acidosis or elevation in temperature drive conformational change.
  • 43.  HSPB5: ~580 kDa oligomer, 10-32 subunits.  Each subunit: Conserved -crystallin domain (ACD) + variable N- and C-termini.  There are 10 human sHSPs.  Polydisperse oligomers.  B-Crystallin (HSPB5) seems to have evolved to resist crystallization! INTRODUCTION and OUTLINE  MAS solid-state NMR and EM: model of HSPB5 oligomer  Solution state studies on the ACD domain: functional questions

Editor's Notes

  1. Protein homeostasis is tightly controlled by a network of chaperones. Roles of chaperone..talk about this. One of them is preventing misfolded proteins from aggregation.
  2. Stresses such as ischemia, hypoxia cause protein misfolding, chaperones kick in. ATP-dep. Structurally amenable. I am going to tell you about sHSP which are challenging since they form polydisperse oligomers.
  3. Both boone and a bane
  4. Subunit: Three domains: conserved ACD, variable N- and C-terminal regions.
  5. Investigated the source of peak doubling with ITC, SEC, and AUC
  6. Peak doubling maps to dimer interface. Dissociation of dimeric subunits into monomers can potentially lead to conformational rearrangement. If so, can we engineer a mutation that’ll trap the oligomer in this form and test its activity.? Transition occurs over the range 7-6.5. In the range where the imidazole rings of histidines titrate. Next slide shows the positions of histidines and their measured pKa values.
  7. H104K shows a single set of peaks corresponding to the monomer conformation.
  8. What are the properties of H104K that make it a better holdase?
  9. Talk about size and bigger particles from EM
  10. Include a slide on measuring pKrs?